UBS Group AG - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTHW and the CUSIP is 23254X110. A total of 6 filers reported holding CYCLO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4
-96.9%
20
-91.8%
0.00%
Q4 2022$127245
-76.4%
0.00%
Q3 2022$0
-100.0%
1,0370.0%0.00%
Q2 2022$1,000
-50.0%
1,037
-9.5%
0.00%
Q1 2022$2,000
-33.3%
1,146
-22.3%
0.00%
Q4 2021$3,000
-40.0%
1,474
-28.8%
0.00%
Q3 2021$5,000
+400.0%
2,070
+909.8%
0.00%
Q2 2021$1,000
-75.0%
205
-79.4%
0.00%
Q1 2021$4,000
+100.0%
993
-46.3%
0.00%
Q4 2020$2,0001,8480.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 63,036$87,0000.41%
AIGH Capital Management LLC 294,931$935,0000.23%
Worth Venture Partners, LLC 74,736$99,0000.05%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Verition Fund Management LLC 800,000$00.00%
UBS Group AG 1,146$2,0000.00%
View complete list of CYCLO THERAPEUTICS INC shareholders